In a Drug Safety Communication released in July 2020, the Food and Drug Administration (FDA) recommends health-care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medications to treat opioid use disorder. According to the FDA, health-care professionals should discuss the availability of naloxone, and consider prescribing it to patients who are at increased risk of opioid overdose. Information on naloxone and information specifically for health-care professionals can be found on the FDA’s website. Also be sure to visit APMA's Opioid Use and Abuse Prevention Page.
Intended for homologous use in the treatment acute and chronic wounds, EpiFix allografts may be stored at ambient conditions for up to 5 years and are available in a variety of sizes. Explore the use of EpiFix® in your wound treatment applications.
Recognizing the symptoms of burnout is the first step toward better self-care.
Editor's note: visit www.apma.org/wellbeing for many resources to help you cope with burnout. See APMA's infographic on the symptoms of physician burnout.
The DERMACLOSE Continuous External Tissue Expander device facilitates rapid tissue movement to reduce or reapproximate wounds. After the initial application has been completed the DERMACLOSE device does not require any additional tightening. Once the desired tissue expansion has occurred the device(s) can be removed and the wound can be closed with suture or staples.
Based on a number of factors, including salary and the cost of malpractice premiums, Mississippi topped the list of physician-friendly states, followed by Alaska and Idaho.
Since our inception in 1990, Ortho-Dynamics has been committed to engineering the highest quality custom orthotics and foot & ankle braces.
Our motto says it all:
"Leadership in Foot Care Technology... Partnership in Foot Care!"
Free Trial! Sold in Podiatry clinics across the country, Cadence provide varying degrees of semi-rigid support with enhanced shock absorbing comfort under the heel and forefoot. Exclusive models available. Call or email for a free pair. 805-458-0567
Disclaimer: Stories from sources other than APMA do not necessarily reflect APMA positions or policies. APMA does not endorse these stories. This content appears in the News Brief to enhance members' understanding of how media coverage shapes perceptions of podiatric medicine, and to educate members about what their patients, legislators and other healthcare professionals are seeing in the media.
